Bretovameran

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Wed Apr 02 20:31:39 GMT 2025` Edited by `admin` on `Wed Apr 02 20:31:39 GMT 2025`
Nucleic Acid Type	MRNA
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	RWD33VV79C
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Bretovameran

Official Name

English

BNT-162b2 Omicron (JN.1)

Preferred Name

English

RNA (recombinant 5?-[1,2-[(3?-O-methyl)m7G-(5??5?)-ppp-Am]]-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 spike glycoprotein secretory signal peptide plus codon-optimized pre-fusion spike glycoprote

Common Name

English

Code System Code Type Description

CAS

3026600-00-7

Created by admin on Wed Apr 02 20:31:39 GMT 2025 , Edited by admin on Wed Apr 02 20:31:39 GMT 2025

PRIMARY

FDA UNII

RWD33VV79C

Created by admin on Wed Apr 02 20:31:39 GMT 2025 , Edited by admin on Wed Apr 02 20:31:39 GMT 2025

PRIMARY

INN

13560

Created by admin on Wed Apr 02 20:31:39 GMT 2025 , Edited by admin on Wed Apr 02 20:31:39 GMT 2025

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_4271	4271 / 4271

Linkage	Site Range	Site Count
Phosphate	1_2-1_4271	4270 / 4270

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOTIDE SUBSTITUTION	[1_1]	SITE_SPECIFIC	A		UNSPECIFIED SUBSTANCE	f4a25b20 (not in database)
NUCLEOSIDE_SUBSTITUTION		RESIDUE_SPECIFIC	U		N1-METHYLPSEUDOURIDINE	09RAD4M6WF